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VimentinThe human heme-regulated eIF2a kinase, also called the human heme-regulated inhibitor (hHRI) is
signiﬁcantly up-regulated particularly at the level of translation during stress. In this report we
show that during lead-stress, the regulation of hHRI mRNA translation is mediated through its 50-
untranslated region (UTR) that interacts with speciﬁc trans-acting factors. Further, vimentin has
been identiﬁed as one of the trans-acting factors that contribute to this regulation.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The heme-regulated eukaryotic initiation factor 2a kinase, also
called the heme-regulated inhibitor (HRI) is a member of the eIF2a
kinase family that regulates translation initiation under various
stress conditions through eIF2a phosphorylation. Phosphorylated
eIF2a cannot be recycled and thus it results in reduced ternary
complex formation (eIF2GTPMet-tRNAi) leading to global reduc-
tion in protein synthesis [1].
Translation of most mRNAs is inhibited under stress conditions,
except a few mRNAs like GCN4, ATF4 and others which are up-reg-
ulated during stress [2]. Interestingly, HRI expression is elevated,
both, at the levels of transcription and translation during anaemia
[3], lead-toxicity and other cytoplasmic stresses like heat-shock
[4]. Stress-induced up-regulation of HRI at the transcriptional level
is regulated by Elk-1, which is activated through the ERK MAP ki-
nase pathway [5]. Previous studies have also indicated that there is
a substantial increase in HRI protein level during drug-induced
anaemia in rabbits, which could not be ascribed to the changes
in its mRNA level, suggesting translational up-regulation of HRI
[3]. However, the mechanism underlying the translation regulation
of HRI remains to be understood.It is well established that various cis-acting components in the
50-untranslated region (UTR) of mRNAs regulate translation. The
cis-acting components include the 50 cap, stem-loop structures, up-
stream open reading frames (uORFs), internal ribosome entry sites
(IRESs), positioning of AUG in Kozak’s context and motifs such as
iron responsive elements (IREs) [6]. Protein output can be varied
by manipulating these components and their deregulation often
leads to various diseases [7]. Human HRI (hHRI) mRNA is 4462
bases in length (NM_001134335) with 50- and 30-UTR being 146
and 2426 bases long. The UTRs of hHRI mRNA are highly structured
and complex. In the present study, we demonstrate that the hHRI
50-UTR acts as an inhibitor of its own translation by binding to
cytoplasmic factors. Further the reduced binding of these factors
during stress leads to translation up-regulation of hHRI. We also
provide evidence that vimentin, an intermediate ﬁlament (IF) pro-
tein, is a component of hHRI messenger ribonucleoprotein (mRNP)
complex that participates in its translation regulation through
interaction with its 50-UTR.2. Materials and methods
2.1. Plasmid constructs
The double-stranded hHRI 50-UTR (50A, Table S1) was cloned
upstream of ﬁreﬂy luciferase gene (Fluc) in pcDNA3 using the
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cloned upstream of Fluc in pcDNA3 was used as the control UTR
for monocistronic assay (Fig. 1B). Renilla luciferase cloned in
pcDNA3 was used for co-transfection. The double stranded hHRI
50-UTR oligo (50D; Table S1) was cloned into pGEM-T Easy vector
(Promega) and further modiﬁed by removal of sequence between
T7 promoter and hHRI 50-UTR (50D) using AatII and SacII to obtain
pGEMT-Easy-HRI-UTR(50D). For monocistronic assay, hHRI 50-UTR
(50D) from pGEMT-Easy-HRI-UTR was sub-cloned into pEGFP-N1
(clone obtained was named phHRI-50UTR EGFP). pEGFP-N1 was
used as control, whose MCS served as a non-speciﬁc sequence up-
stream of the EGFP (Fig. 2A). pR/DE-EMCV/F and pR/DE/F plasmids
were a kind gift from Dr. Peter Sarnow at Stanford University. pR/
DE-HRI/F was prepared by cloning hHRI 50-UTR (50D) into NcoI and
EcoRI sites.
2.2. In vitro cell culture, transfection and dual luciferase reporter assay
K562 cells were cultured as described earlier [5]. For lead-
stress, cells were exposed to 100 lg/mL of lead acetate for 8 h.
Transfection with appropriate plasmid constructs was carried out
using Lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s protocol. Dual luciferase reporter assay was performed
48 h post-transfection using Dual-Luciferase Reporter Assay kit
(Promega).Fig. 1. Stem-loop 1 of hHRI 50-UTR (50A) up-regulates translation of the downstream rep
different regions from which the oligonucleotides were synthesized. (B) Schematic repres
as predicted by Mfold. (D) Rows I and II represent the results of RT-PCR analysis of K562
respectively. Optical density ratios of Fluc/Rluc are indicated. The experiments were perf
Transfection assay proﬁle of monocistronic plasmids (B) introduced into K562 cells. T
mean ± S.D. of 3 independent experiments. Fluc/Rluc ratio of control samples was conside
and asterisk indicate statistically signiﬁcant differences between samples 1 and 2 and s2.3. RNA extraction and RT-PCR
Total RNA from transfected K562 cells or the immunoprecipi-
tated samples was extracted using TRIzol reagent (Invitrogen).
1 lg RNA was reverse transcribed by using AMV-reverse transcrip-
tase. Fluc, Rluc, EGFP, b-actin and hHRI cDNAs were ampliﬁed
using the respective gene speciﬁc PCR primers (Table S1).
2.4. Preparation of protein extracts and immunoblotting
Total soluble protein was extracted from cells by homogeniza-
tion in lysis buffer (50 mM Tris–HCl, pH 8.0; 5 mM EDTA; 0.1% Tri-
ton X-100; 1 mM PMSF) and cleared by centrifugation at
11 000  g, 30 min at 4 C. Cytoplasmic protein extract (CPE) was
prepared as described elsewhere [8]. Equal quantity of proteins
were resolved on SDS–PAGE and transferred onto nitrocellulose
membranes. Blots were probed with anti-GFP (Santa Cruz Biotech-
nology Inc.) and anti-Actin (Sigma–Aldrich) antibodies according
to manufacturers’ instructions. Signals were documented and ana-
lyzed using Gel Doc XR System and Quantity One Software (Bio-
Rad Laboratories, USA), respectively.
Intermediate ﬁlaments were prepared as describe previously
[9]. Brieﬂy K562 cells were washed with ice cold PBS and then
resuspended in lysis buffer (20 mM Hepes, pH 7.5; 150 mM NaCl;
1% NP-40; 10% glycerol; protease inhibitor cocktail) and incubatedorter gene. (A) Schematic representation of the hHRI mRNA depicting the UTRs and
entation of monocistronic plasmids used for reporter assays. (C) Structure of the 50A
cells transfected with monocistronic plasmids using Rluc- and Fluc-speciﬁc primers,
ormed under normal and lead-stress conditions (100 lg/mL lead acetate for 8 h). (E)
he F/R ratio is represented in arbitrary units (AU). Each value is represented as
red as 1 arbitrary unit (AU). Test sample quantiﬁcation was done accordingly. Hash
amples 3 and 4, respectively (p < 0.05, Student’s t test).
Fig. 2. Stem-loop 2 and 3 of hHRI 50-UTR (50D) up-regulates translation of the downstream reporter gene. (A) Schematic representation of monocistronic plasmids used for
reporter assays. (B) Structure of the hHRI 50-UTR as predicted by Mfold. (C) Rows I and II represent the results of RT-PCR analysis of K562 cells transfected with monocistronic
plasmids using EGFP- and b-actin-speciﬁc primers, respectively. Rows III and IV represent the results of Western blot analysis of transfected K562 lysate with anti-EGFP and
anti-b-actin antibodies, respectively. In both the experiments, optical density ratios of EGFP/b-actin are indicated. (D) Densitometric analysis of III and IV presented as EGFP/b-
actin optical density ratio. The values are the mean ± S.D. of data obtained from 3 independent experiments. EGFP/b-actin optical density ratio of control samples was
considered as 1 arbitrary unit (AU). Test sample quantiﬁcation was done accordingly. Hash and asterisk indicate statistically signiﬁcant differences between samples 1 and 2
and samples 3 and 4, respectively (p < 0.05, Student’s t test).
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(Cytosol + membrane) and the insoluble fraction (Intermediate ﬁl-
ament) were separated by centrifugation at 5200 RPM at 4 C for
30 min. The insoluble intermediate fraction was then resuspended
in solubilisation buffer (lysis buffer + 0.1% SDS) and incubated at
37 C for 10 min and was used in RNA–EMSA experiments.
2.5. In vitro transcription of hHRI 50-UTR and RNA–EMSA studies
Transcription reactions were performed with 1 lg linearized
pGEMT-Easy-HRI-UTR plasmid as described previously [10]. The
fragments of hHRI 50-UTR (50A, 50B, 50C and 50D, Table S1) were
transcribed from the annealed oligos corresponding to the respec-
tive fragments along with T7 promoter sequence [10]. The RNA
electrophoretic mobility shift assay (RNA–EMSA) was performed
with 6 lg K562 extract [11]. For competition experiments, unla-
belled hHRI 50-UTR RNA was added to the gel-shift reaction mix
in 500-fold excess and incubated for 10 min and chilled on ice
for 5 min before addition of the extract. For UV-crosslinking exper-
iments, the RNA–Protein complexes were prepared as described
above and UV-irradiated for 15 min at 4 C with 100 mJ/cm2 using
a Hoefer UV crosslinker (UVC500). After the UV crosslinking the
samples were incubated with 1U of RNase A and 40U of RNase
T1 (Ambion) for 10 min at 37 C. The samples were analysed on
SDS–PAGE as described previously [10].2.6. RNA immunoprecipitation
RNA immunoprecipitation was done using untreated K562
cells and anti-vimentin antibody (Abcam, UK) as described else-
where [12]. Brieﬂy, actively growing K562 cells were treated with
formaldehyde (1% Wt/Vol ﬁnal concentration) and incubated for
10 min at room temperature with intermittent shaking. Glycine
was added to a ﬁnal concentration of 0.25 M and incubated for
5 min to neutralize excess formaldehyde. The cells were washed
thrice with ice cold PBS, and resuspended in 4 ml of RIPA buffer
(50 mM Tris–HCl, pH 7.4; 1% Nonidet P-40; 0.5% sodium deoxy-
cholate; 0.05% SDS; 1 mM EDTA; 150 mM NaCl) containing prote-
ase inhibitors and 50 units/ml RNase inhibitor. Cell suspensions
were sonicated and centrifuged at 13 000 rpm at 4 C for
10 min to remove insoluble material. 25% of the supernatant
was incubated with 5 ll of anti-vimentin or control IgG antibod-
ies for 1 h followed by addition of 5 ll of protein A/G-agarose
beads at 4 C for 4 h. Subsequently the beads were collected by
centrifugation at 1000 rpm for 2 min and washed six times with
1 ml of RIPA buffer, at high-salt (1 M NaCl) conditions. The beads
after the wash were suspended in 200 ll of 50 mM Tris–HCl, pH
7.0, 5 mM EDTA, 10 mM DTT, 1% SDS followed by incubation at
70 C for 45 min to reverse the crosslinks. The immunoprecipi-
tated RNAs were isolated with TRI Reagent and analyzed by
RT-PCR using HRI speciﬁc primers.
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3.1. hHRI 50-UTR up-regulates translation of reporter genes
HRI gets activated by heavy metal toxicity (lead acetate and so-
dium arsenite) and inhibits global translation initiation, hence,
lead stress was chosen [4,13]. However, the mechanism of transla-
tion activation of HRI under stress conditions has not been eluci-
dated. We therefore chose lead stress to understand the
mechanism of translation regulation of HRI. The hHRI 50-UTR is
146 bases long and is predicted to fold into a highly stable complex
secondary structure (with 2 stem-loops, 5 interior-loops and 2
bulge-loops) with free energy of 78.3 kcal/mol (Fig. S1). We have
fragmented the 50-UTR of HRI into multiple regions and examined
the role of these different regions, speciﬁcally the region (50A) that
forms stem-loop 1 and the region (50D) that forms stem-loop 2
(Fig. S1) on translation regulation. These sequences were cloned
upstream to Fluc or EGFP reporter genes, and the translation of
these reporters were assessed under normal and stress conditions.
The region 50A when folded independently was predicted to form 2
stem-loops and 1 junction-loop with free energy of 15.80 kcal/
mol (Fig. 1C). While, stem-loop 2 (50D) when folded independently
was predicated to form 2 stem-loops and 3 bulge-loops with free
energy of 50.30 kcal/mol (Fig. 2B). Fluc expression in the pres-
ence of hHRI 50-UTR (50A) was similar to translation of Fluc under
control UTR in cells grown in normal conditions (Fig. 1E; bars 1
and 3). However, under lead-stress, Fluc with an upstream hHRI
50-UTR (50A) exhibited a 21% increase in its translation (Fig. 1E;
bars 3 and 4) as compared to untreated cells. On the other hand,
Fluc under control UTR showed 22% less translation (Fig. 1E; bars
1 and 2) without any signiﬁcant changes in mRNA levels
(Fig. 1D; rows I and II). This correlates with the fact that heavy me-
tal toxicity induces expression and activity of HRI, which brings
down global protein synthesis.
Expression of another reporter, EGFP was also assessed, simi-
larly. Normalized expression of EGFP in presence of hHRI 50-UTR
(50D) was signiﬁcantly lower (70%) than EGFP alone under normal
condition (Fig. 2C; row III; lane 3 compared to lane 1). This can be
explained by the fact that hHRI 50-UTR is predicted to be highly
structured and has features that are incompatible with efﬁcient
ribosomal scanning. However, under lead-stress, EGFP with an up-
stream hHRI 50-UTR (50D) exhibited a 200% increase in its transla-
tion as compared to untreated cells (Fig. 2C; row III; lanes 3 and 4)
without any change in mRNA level (Fig. 2C; rows I and II). There
was 55% decrease in translation of EGFP alone under lead stress
(Fig. 2C; row III; lanes 1 and 2) due to activation of HRI. The expres-
sion of EGFP was normalized to b-actin levels and the percent
change of EGFP was calculated (Fig. 2D). This demonstrated
that the predicted stem-loops of hHRI 50-UTR were capable of
up-regulating translation of reporter genes (though the translation
up-regulation was more evident in stem-loop 2) speciﬁcally, under
lead-stress, which could be attributed either to its inherent IRES
activity or to differential interaction between the trans-acting
factors and cis-acting elements in the hHRI 50-UTR.3.2. hHRI 50-UTR does not seem to have an IRES activity
In order to determine whether hHRI 50-UTR could mediate cap-
independent internal initiation, we assessed the region 50D (as in-
crease in translation was more evident with this region) for IRES
activity. The 50D region was cloned between the Renilla luciferase
and Fireﬂy Luciferase ORFs. Thus the cap-dependent translation
will be responsible for Renilla activity, while the IRES activity of
the fragment was assessed by the luciferase expression. The bicis-
tronic plasmids pR/DE-EMCV/F, pR/DE/F, pR/DE-HRI/F and theinternal control plasmid pEGFP-N1 were transiently co-transfected
into K562 cells followed by luciferase assay (Fig. 3A). The ﬁreﬂy
luciferase to renilla ratio for the pR/DE-HRI/F was similar to that
of the null control vector (pR/DE/F) that did not have a functional
IRES, (Fig. 3B). The ratios were not signiﬁcantly altered either in
normal or lead stress conditions. Under similar conditions the
EMCV IRES activity was at least 10-fold higher than that of the null
vector. These results suggest that the 50D region of the HRI 50UTR
lacks an inherent IRES activity.
3.3. Differential interaction of speciﬁc cytoplasmic proteins with the
hHRI 50-UTR under lead-stress
In the absence of any evidence for IRES activity in the hHRI 50-
UTR (50D), we determined whether cellular factors interact with
the elements in hHRI 50-UTR (50D) by performing RNA electropho-
retic mobility shift assay (RNA–EMSA) with normal K562 CPE.
RNA–EMSA results indicated the presence of cytoplasmic factors
that speciﬁcally bind to the region 50 D. Two speciﬁc RNA–protein
complexes (C1 and C2) were observed in normal conditions but
were reduced after treatment with lead acetate (Fig. 4A; lanes 2
and 3). This reduction was more signiﬁcant in case of C1. It sug-
gests that reduced binding of proteins to hHRI 50-UTR (50D) may
be involved in the increased HRI protein translation under lead-
stress. The speciﬁcity of these complexes was analyzed by adding
an excess of unlabelled hHRI 50-UTR fragments (50 A, B, C or D) or
control insulin 50-UTR (MIN, mins 2) as competitors during EMSA.
While all these hHRI 50UTR fragments were able to compete for the
complex formation to varying degrees, the control insulin UTRs
were unable to do so even when present in 500-fold molar excess
(Fig. 4B). The results indicate that the complex formed is speciﬁc to
hHRI-UTR RNA and K562 cellular factors. Amongst the fragments
of hHRI, the 50A region competed most efﬁciently indicating that
the 50A region has higher afﬁnity or kinetic stability towards the
K562 cytoplasmic factors. The functional signiﬁcance of the high
afﬁnity binding of 50A is yet to be assessed. Further, we studied
the interaction of hHRI 50-UTR (50D) with CPE from untreated and
lead-stressed K562 cells by UV-crosslinking to determine the
molecular weight of the proteins which associate with hHRI 50-
UTR (50D). At least, three proteins (P1, P2 and P3) of molecular
weights (MWs) 120, 80 and 55 kDa were observed to which the
label from hHRI 50-UTR (50D) was crosslinked (Fig. 4C; lanes 2
and 3).3.4. Identiﬁcation of vimentin as a part of hHRI mRNP complex
In an attempt to identify the factors binding to hHRI 50-UTR
(50D), afﬁnity chromatography using biotinylated hHRI 50-UTR
(50D) as the ligand was done. As a negative control for pull-down
assay, we took the biotinylated pGEM-T Easy MCS which is a non-
speciﬁc sequence for mRNP formation. The RNA–protein com-
plexes were prepared by incubating K562 lysates with biotin
labelled hHRI 50-UTR (50D) or pGEM-T Easy MCS and were allowed
to bind to the streptavidin beads and eluted with TE followed by
TE-SDS. Protein bands corresponding to approximate MWs of
100, 60, 55 and 47 kDa were observed. While the 100 kDa and
the 55 kDa bands could correspond to those seen in UV crosslink-
ing experiments, the protein corresponding to 80 kDa, which was
observed in UV crosslinking experiments could not be detected
in the RNA afﬁnity pull down. The proteins corresponding to the
indicated bands (Fig. 5A, lanes 4 and 6) were analysed by mass
spectrometry. The 100 kDa band, which was also seen in the
UV crosslinking experiments could not be identiﬁed with conﬁ-
dence, while the 55 kDa protein band was identiﬁed as human
vimentin. Vimentin is a type III intermediate ﬁlament (IF) protein
Fig. 3. hHRI 50-UTR does not exhibit an IRES activity. (A) Schematic representation of bicistronic constructs used in transient transfection assays. (B) Transfection assay proﬁle
of bicistronic plasmids introduced into K562 cells. The F/R ratio is represented in arbitrary units (AU), where F/R ratio of empty plasmid pR/DE/F was taken as 1. Each value is
represented as mean ± S.D. of three independent experiments. Transfection efﬁciencies were normalized by pEGFP-N1 co-transfection. The experiments were performed
under normal and lead-stress conditions (100 lg/mL lead acetate for 8 h).
Fig. 4. Differential interaction of speciﬁc cytoplasmic proteins with hHRI 50-UTR under lead-stress. (A) RNA–EMSA proﬁle of the hHRI 50-UTR (50D) as the free probe incubated
with control or lead acetate treated K562 CPE. The arrow head indicates the two complexes formed C1 and C2. (B) Competitive RNA–EMSA in which 500-fold excess of cold
probes as mentioned in the ﬁgure was incubated with labelled hHRI 50-UTR probe (50D) and K562 CPE. Lane 1, free probe; lane 2, lead acetate treated K562 CPE incubated with
radiolabeled 50D; lane 3, control K562 CPE incubated with radiolabelled 50D; lanes 4–7, control K562 CPE incubated with 500-fold excess of radiolabelled probes 50D (lane 4),
50A (lane 5), 50B (lane 6) and 50C (lane 7), respectively; lanes 8–9, 500-fold excess of non-speciﬁc cold RNA (insulin 50-UTR; mlns2 and MIN) incubated with labelled hHRI 50-
UTR (50D) and K562 CPE showing no competition. (C) Analysis of RNA–protein interaction by UV-crosslinking experiment. Lane 1, free probe; lane 2, UV-crosslinked K562
(control) CPE with radiolabelled hHRI 50-UTR; lane 3, UV-crosslinked K562 (lead-stress) CPE with radiolabelled hHRI 50-UTR. P1–P3 are complexes of decreasing molecular
weights.
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the 55 kDa protein, as observed earlier, in UV-crosslinking studies
(Fig. 4C). Immunodetection with anti-vimentin antibody was done
to conﬁrm its presence in the RNA pull-down samples, which were
analyzed by MALDI TOF/TOF. Vimentin was found to be present
speciﬁcally in TE and TE-SDS elutes (Fig. 5B, lanes 3 and 5) from
hHRI 50-UTR (50D) pull down sample. To further conﬁrm the
association of vimentin with hHRI 50-UTR (50D), an RNA-IP was
performed with anti-vimentin antibody using K562 cell extract.
RT-PCR analysis of the IP samples conﬁrmed that hHRI mRNA
was associated with vimentin protein in vivo (Fig. 5C, lane 6).
The binding of vimentin to hHRI mRNA (50D) was also assessed
by RNA–EMSA with puriﬁed bacterially expressed recombinant
vimentin (Abcam, USA). We were unable to detect any hHRI 50-
UTR (50D) binding activity with puriﬁed recombinant vimentin
(data not shown). Previously it has been shown that collagen A1
mRNA interacts with vimentin intermediate ﬁlaments [9]. In view
of this report, we attempted to determine whether hHRI mRNA
(50D) also associates with vimentin intermediate ﬁlament. Weprepared intermediate ﬁlament extract from K562 cells (control
and lead-exposed) and assessed hHRI mRNA binding activity in
these extracts. The results indicate that most of the HRI 50-UTR
(50D) RNA binding activity of vimentin is retained in the interme-
diate ﬁlament fraction (Fig. 5D). Further, no signiﬁcant difference
in complex formation could be observed between the control and
lead-treated intermediate ﬁlament extracts. These results clearly
suggest that HRI mRNA associates with vimentin particularly in
its ﬁlament form.
4. Discussion
We have investigated the mechanism of 50-UTR mediated trans-
lation upregulation of hHRI under lead-stress. Insertion of the hHRI
50-UTR (predicted stem-loop 1 and 2) enhanced the translation of
the reporter EGFP/Fluc protein (in vivo) on exposure to lead-stress
(which is known to cause eIF2a phosphorylation-mediated inhibi-
tion of translation initiation by HRI). Since, the mechanism of such
enhanced translation of hHRI mRNA during stress due to its 50-UTR
Fig. 5. Vimentin interacts with hHRI 50-UTR. (A) RNA pull-down assay of K562 CPE using biotinylated control non-speciﬁc RNA (pGEM-T Easy MCS) and hHRI 50-UTR RNA. The
proteins bound to the RNA were eluted with Tris–EDTA (TE) buffer and TE-SDS. The ﬂow through (FT) and elutes were resolved by SDS–PAGE and detected by Coomassie
staining. Lane 1, ﬂow through (FT) from control; lane 2, FT from hHRI 50-UTR; lane 3, TE elute from control; lane 4, TE elute from hHRI 50-UTR; lane 5, TE-SDS elute from
control; lane 6, TE-SDS elute from hHRI 50-UTR; lane 7, empty; lane 8, BSA; lane 9, protein MWmarkers (NEB). Arrows indicate eluted proteins from columns. (B) Western blot
of RNA pull-down samples from (A) probed with anti-vimentin antibody. Lane 1, ﬂow through (FT) from hHRI; lane 2, FT from control; lane 3, TE elute from hHRI; lane 4, TE
elute from control; lane 5, TE-SDS elute from hHRI; lane 6, TE-SDS elute from control; lane 7, marker. (C) In vivo RNA-binding activity of vimentin was demonstrated by
immunoprecipitation/RT-PCR assay. Untreated K562 lysates were immunoprecipitated with mouse IgG (negative control) or anti-vimentin MAb. PCR was performed using
hHRI-speciﬁc primers and cDNA prepared using RNA isolated from immunoprecipitates. Lane 1, 100 bp marker; lane 2, Input cDNA; lane 3, Input RNA; lane 4, mouse IgG-
immunoprecipitated cDNA; lane 5, mouse IgG-immunoprecipitated RNA; lane 6, vimentin MAb-immunoprecipitated cDNA; lane 7, vimentin MAb-immunoprecipitated RNA.
Reverse transcriptase (RT) was not added for samples in lanes 3, 5 and 7. (D) hHRI mRNA (50D) binding activity of vimentin was detected in the intermediate ﬁlament fraction
by RNA–EMSA. Both soluble and intermediate ﬁlament extracts obtained from K562 cells (control and lead-exposed) were incubated with radio-labeled HRI 50UTR RNA (50D)
and the complexes were resolved on a 6% native PAGE and autoradiographed. The extracts used are as indicated above the lanes. Arrows indicate the positions of retarded
bands.
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ment, as certain mRNAs carrying IRES elements are translated
more efﬁciently on eIF2a phosphorylation [15]. However, there
was no detectable IRES activity in the hHRI 50-UTR (50D) under nor-
mal and stress conditions.
Enhanced expression of EGFP/Fluc (containing the 50-UTR of
hHRI, fragments 50A and 50D) during stress, despite the presence
of predicted strong secondary structures in the hHRI 50-UTR, indi-
cates a possible binding of trans-acting factors to the hHRI 50-UTR
to mediate translation repression or stimulation [10]. We therefore
attempted to identify the trans-acting factors that may speciﬁcally
bind to the hHRI 50-UTR (50D) and regulate hHRI mRNA translation
during normal or stress conditions. RNA–protein interaction stud-
ies (RNA–EMSA) revealed the presence of 2 speciﬁc complexes C1
and C2, formed with differential binding of protein to hHRI 50-UTR
(50D) mRNA under lead-stress. This differential binding of proteins
to hHRI 50-UTR (50D) is involved in enhanced translation of both
EGFP/Fluc (in our experiment) and HRI itself under stress condi-
tions in vivo. We postulate that these complexes inhibit HRI trans-
lation during normal physiological condition through their
interaction with its 50-UTR. While during cellular stress, decreased
binding of some of the factors of these complexes to hHRI 50-UTRleads to increased accessibility of the ribosome to the 50-UTR,
resulting in higher translation of hHRI mRNA.
Association of cytoskeleton with mRNPs in the context of local-
isation of mRNA and translation is well studied [16], however little
is known about vimentin’s association with mRNPs. Vimentin
plays a role in the storage of ribonucleoprotein particles in general
and non-translating ribosomes in particular, in the cytoplasm of
animal cells [17]. It also serves as a scaffold for the attachment of
polysomes that are active in viral protein synthesis [18]. Morrison
and Ladomery, 2006 [19] have reported association of Wilms Tu-
mor 1(WT1) mRNA with vimentin, however the signiﬁcance of
the association remained unexplained. Collagen mRNA was shown
to associate with vimentin ﬁlaments [9]. Further, it was shown that
the LARP6 binds speciﬁcally to the stem loop region in the 50-UTR
of collagen mRNA and LARP6 also associates with vimentin in the
intermediate ﬁlaments. More recently it was shown that disrup-
tion of intermediate ﬁlaments with speciﬁc drugs destabilizes col-
lagen mRNA and prevents ﬁbrosis [20]. We identiﬁed vimentin as a
part of the hHRI mRNP complex by RNA pull-down, MALDI TOF/
TOF and RNA-IP analyses. Presence of vimentin in control TE-SDS
elutes (Fig. 5B, lane 6) indicates probable non-speciﬁcity. However,
the quantity of vimentin is 6-fold more in hHRI (50D) compared to
480 S. Chatterjee et al. / FEBS Letters 587 (2013) 474–480the control RNA (Fig. 5B). Further, vimentin binds to naturally
occurring single stranded nucleic acids (in vitro) with high G-
content [21]. hHRI 50-UTR (50D) and pGEM-T Easy MCS is approxi-
mately 45% and 28% G-rich, respectively. We also observed that the
HRI binding activity is present in the vimentin intermediate ﬁla-
ment fraction. These results taken together suggest that vimentin
interacts with hHRI 50-UTR (50D). The molecular weight of vimentin
approximately corresponds to P3 band in UV-cross linking experi-
ment, however, the fact that the levels of vimentin do not change
with stress, leads us to hypothesize that it may serve as a scaffold
for hHRI mRNA and interacting proteins. We believe that vimentin
is probably not associating directly with the hHRI mRNA but may
be associating with speciﬁc RNA binding proteins that may regu-
late the translation of hHRI. UV-cross linking experiments also de-
tected 2 other proteins P1 and P2. The quantity of protein P1
decreases during stress while that of P2 remains unchanged. We
believe that P1 may be actively involved in translation regulation
of hHRI mRNA and P2 may function as a scaffold protein. However,
the identity of P1 and P2 could not be ascertained.
Although, our study is focussed on determining the role of hHRI
50-UTR in its translation regulation, we have also investigated the
possible involvement of hHRI 30-UTR in its translation regulation
including stabilisation. However, the results indicate that the 3’-
UTR of hHRI mRNA does not play any signiﬁcant role in its transla-
tion regulation (data not shown).
HRI is an important protein for global regulation of translation
in cells of erythroid lineage, in particular. During stress, it generally
inhibits global translation barring that of a few mRNAs, and HRI is
one of them [3]. The up-regulation of hHRI further inhibits global
translation activity in a cell which assures the conservation of en-
ergy during stress. To balance between the basal level of expres-
sion and induced expression during stress, cis-sequences located
in the hHRI 50-UTR interact with cytoplasmic protein factors differ-
entially to yield quantitative variation of HRI protein expression. In
the present study, we found 3 such factors and identiﬁed vimentin
as one of the components of hHRI mRNP complexes.
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